Comparative analysis of the effectiveness of chondroitin sulfate, hyaluronic acid and arthroscopy at the initial stages of hip osteoarthritis
Background. The efficiency of modern drugs that modify the course of the disease is still doubtful, especially, their influence on the long-term effects of hip osteoarthritis. Besides, the following question remains controversial: what is more effective in treatment of osteoarthrosis — arthroscopy or drug therapy? The purpose was to evaluate and to compare the clinical efficiency of preparations of hyaluronic acid, chondroitin sulfate, and also arthroscopy in the treatment of the initial stages of coxarthrosis for 6 months. Materials and methods. In this study, we have study the clinical efficiency of therapy by chondroitin sulfate preparations, hyaluronic acid preparation administered intraarticularly, and arthroscopy in patients with the initial stages of coxarthrosis. The severity of pain syndrome was evaluated on the visual analog scale, the movement function of the hip — on the modified Harris scale, and also a therapeutic effect was assessed, in opinion of patient and doctor. Clinical indexes were determined at baseline, and on months 1, 3 and 6. Results. It was found that the combination of non-steroidal anti-inflammatory drugs with symptom-modifying drugs of delayed action contributes to the reduction of severity of pain in patients with initial stages of coxarthrosis. Intraarticular introduction of hyaluronic acid assists the improvement of movement function of the affected joint and everyday activity of these patients. After arthroscopy, the positive dynamics of pain syndrome and functional ability of the hip joint is marked in 3 months after the surgery, and in 6 months — significantly lower intensity of pain and improvement of functional capability of patients compared to those who received medication. Conclusions. According to the results of the overall assessment of treatment effectiveness by the patient and the physician on the basis of six-month therapy, more pronounced improvement of the functional state of hip joints was detected after arthroscopic treatment than against the background of the pharmacotherapy.
Full Text:PDF (Українська)
Mironov SP, Omel'ianenko NP, Orletskii LK, Markov IuA, Karpov IN. Оsteoarthrosis: the current state of the problem (analytical review). Vestnik travmatologii i ortopedii imeni N.N. Priorova. 2001;2:96-99. (in Russian).
Frank JM, Harris JD, Erickson BJ, et al. Prevalence of femoroacetabular impingement imaging findings in asymptomatic volunteers: a systematic review. Arthroscopy. 2015 Jun;31(6):1199-204. doi: 10.1016/j.arthro.2014.11.042.
Zhang W, Doherty M, Arden N, et al. EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2005 May;64(5):669-81. doi: 10.1136/ard.2004.028886.
Bruyère O, Altman RD, Reginster JY. Efficacy and safety of glucosamine sulfate in the management of osteoarthritis: Evidence from real-life setting trials and surveys. Semin Arthritis Rheum. 2016 Feb;45(4 Suppl):S12-7. doi: 10.1016/j.semarthrit.2015.11.011.
Roman-Blas JA, Castañeda S, Sánchez-Pernaute O, Largo R, Herrero-Beaumont G; CS/GS Combined Therapy Study Group. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Arthritis Rheumatol. 2017 Jan;69(1):77-85. doi: 10.1002/art.39819.
Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Effect of glucosamine or chondroitin sulfate on the osteoarthritis progression: a meta-analysis. Rheumatol Int. 2010 Jan;30(3):357-63. doi: 10.1007/s00296-009-0969-5.
Migliore A, Massafra U, Bizzi E, et al. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study. Arch Orthop Trauma Surg. 2011 Dec;131(12):1677-85. doi: 10.1007/s00402-011-1353-y.
Miller LE, Sloniewsky MJ, Gibbons TE, Johnston JG, Vosler KD, Nasir S. Long-term clinical benefit and cost-effectiveness of an 8-week multimodal knee osteoarthritis management program incorporating intra-articular sodium hyaluronate (Hyalgan®) injections. J Pain Res. 2017 May 5;10:1045-1054. doi: 10.2147/JPR.S132497.
Witteveen AG, Hofstad CJ, Kerkhoffs GM. Hyaluronic acid and other conservative treatment options for osteoarthritis of the ankle. Cochrane Database Syst Rev. 2015 Oct 17;(10):CD010643. doi: 10.1002/14651858.CD010643.pub2.
Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S240-52. doi: 10.1002/acr.20543.
Harris WH. Traumatic arthritis of the hip after dislocation and acetabular fractures: treatment of mold arthroplasty. An end-result study using a new method of result evaluation. J Bone Joint Surg Am. 1969 Jun;51(4):737-55. PMID: 5783851.
- There are currently no refbacks.
Copyright (c) 2017 Bol', Sustavy, Pozvonochnik - Pain, Joints, Spine
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2017